Direct-Acting Antivirals: Side Effects Management Handouts - Hepatitis C
These handouts feature tips for patients coping with common side effects of hepatitis C treatment. Also see patient handouts on Taking Your Therapy .
Before starting treatment with these direct-acting antivirals, all patients should be screened for current or past HBV infection .
-
Vosevi
®
(Sofosbuvir/Velpatasvir/Voxilaprevir)
(348K)
-
Acid-Reducing Medications: Interactions with Harvoni
®
and Epclusa
®
(275K)
-
Mavyret
TM
(Glecaprevir/Pibrentasvir)(734K)
-
Epclusa
®
(Sofosbuvir/Velpatasvir)(108K)
-
Epclusa
®
(Sofosbuvir/Velpatasvir) + Ribavirin (113K)
-
Zepatier
TM
(171K)
-
Zepatier
TM
+ Ribavirin (173K)
-
Harvoni
®
(Ledipasvir/Sofosbuvir) (348K)
-
Harvoni
®
(Ledipasvir/Sofosbuvir) + Ribavirin (1.2M)